Skip to main content
SpringerLink
Log in

Risks and Benefits of Drugs Used in the Management of Postoperative Nausea and Vomiting

  • Review Articles
  • Risk-Benefit Assessment
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

Postoperative nausea and vomiting (PONV) is an age-old problem; more so since the blooming of ambulatory or day surgery centres within the last 2 decades. The aetiology of PONV is multifactorial. The incidence of PONV is usually higher in women and children than in men. PONV not only causes patient discomfort, anxiety in mild cases, and serious complications in severe cases, it also decreases cost efficiency.

The benefits and risks of old and new antiemetic drugs used worldwide to treat PONV are discussed in this article, including the newly developed serotonin 5-hydroxytryptamine 3 (5HT3) antagonists. All the medications currently used to treat PONV have both advantages and disadvantages. If used indiscriminately to treat patients who have no problems with PONV, the risks of adverse effects often outweigh the benefits. The patient’s history and the nature of the surgery are good indicators for defining those at risk from PONV; for patients at risk preventive treatment is essential. However, it is almost impossible to pick one agent or one combination as the therapy of choice using the present available data. A patient history of a favourable response to a previously used antiemetic would make that drug the agent of choice, So far, the newcomers, the 5HT3 antagonists, have fewer reported adverse effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beattie WS, Lindblad T, Buckley DN, et al. Menstruation increases the risk of nausea and vomiting after laparoscopy: a prospective randomized study. Anesthesiology 1993; 78: 272–6

    PubMed  CAS  Google Scholar 

  2. Ramsay TM, McDonald PF, Fragher ED. The menstrual cycle and nausea and vomiting after wisdom teeth extraction. Can J Anaesth 1994; 41: 798–801

    PubMed  CAS  Google Scholar 

  3. Buckley DN, Beattie WS, Beattie AE. Risk factors in postoperative nausea and vomiting. Anesthesiology 1993; 79: A1092

    Google Scholar 

  4. Honkavaara P, Lehtinen AM, Hovorka J, et al. Nausea and vomiting after gynaecological laparoscopy depends upon the phase of the menstrual cycle. Can J Anaesth 1991; 38: 876–9

    PubMed  CAS  Google Scholar 

  5. Kauste A, Tuominen M, Heikkinen H, et al. Droperidol, alizapride and metoclopramide in the prevention of postoperative emetic sequelae. Eur J Anaesthesiol 1986; 3: 1–9

    PubMed  CAS  Google Scholar 

  6. Madej TH, Simpson KH. Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following major gynaecological surgery. Br JAnaesth 1986; 58: 884–7

    CAS  Google Scholar 

  7. Kenny GNC, Oates JDL, Lesser J, et al. Efficacy of orally administered ondansetron in the prevention of postoperative nausea and vomiting: a dose ranging study. Br J Anaesth 1992; 68: 466–70

    PubMed  CAS  Google Scholar 

  8. Dupeyron JP, Conseiller C, Levarlet M, et al. The effect of oral ondansetron, a new 5-HT3 receptor antagonist, in the prevention of postoperative nausea and vomiting after major gynaecological surgery performed under general anaesthesia. Anaesthesia 1993; 48: 214–8

    PubMed  CAS  Google Scholar 

  9. Knapp MR, Beecher HK. Postanesthetic nausea, vomiting and retching. JAMA 1956; 160: 376–85

    CAS  Google Scholar 

  10. Smessaert A, Schehr CA, Artusio JF. Nausea and vomiting in the immediate postanesthetic period. JAMA 1959; 170: 2072–6

    CAS  Google Scholar 

  11. Purkis IE. Factors that influence postoperative vomiting. Can Anaesth Soc J 1964; 11: 335–53

    PubMed  CAS  Google Scholar 

  12. Zelcer J, Wells DG. Anaesthetic-related recovery room complications. Anaesth Intensive Care 1987; 15: 168–74

    PubMed  CAS  Google Scholar 

  13. Abramowitz MD, Oh TH, Epstein BS, et al. The antiemetic effect of droperidol following outpatient strabismus surgery in children. Anesthesiology 1983; 59: 579–83

    PubMed  CAS  Google Scholar 

  14. Hardy JF, Charest J, Girouard G, et al. Nausea and vomiting after strabismus surgery in preschool children. Can Anaesth Soc J 1986; 33: 57–62

    PubMed  CAS  Google Scholar 

  15. Lerman J, Eustis S, Smith DR. Effect of droperidol pretreatment on postanesthetic vomiting in children undergoing strabismus surgery. Anesthesiology 1986; 65: 322–5

    PubMed  CAS  Google Scholar 

  16. Gold BS, Kitz DS, Lecky JH, et al. Unanticipated admission to the hospital following ambulatory surgery. JAMA 1989; 262: 3008–10

    PubMed  CAS  Google Scholar 

  17. Meridy HW. Criteria for selection of ambulatory surgical patients and guidelines for anesthetic management: a retrospective study of 1553 cases. Anesth Analg 1982; 61: 921–6

    PubMed  CAS  Google Scholar 

  18. Palazzo MG, Strunin L. Anesthesia and emesis. I. Etiology. Can Anaesth Soc J 1984; 31: 178–87

    PubMed  CAS  Google Scholar 

  19. Keats AS. Preoperative use of antiemetics [editorial]. Anesthesiology 1960 Mar–Apr: 213

  20. Clarke RSJ, Dundee JW, Love WJ. Studies of drugs given before anaesthesia VIII: Morphine 10mg alone and with atropine or hyoscine. Br J Anaesth 1965; 37: 772–7

    PubMed  CAS  Google Scholar 

  21. Dundee JW, Moore J, Clarke RSJ. Studies of drugs given before anaesthesia V: pethidine 100mg alone and with atropine or hyoscine. Br J Anaesth 1964; 36: 703–10

    PubMed  CAS  Google Scholar 

  22. Clissold SP, Heel RC. Transdermal hyoscine (scopolamine): a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1985; 29: 189–207

    PubMed  CAS  Google Scholar 

  23. Putcha L, Cintrón, Tsui J, et al. Pharmacokinetics and oral bioavailability of scopolamine in normal subjects. Pharm Res 1989; 6: 481–5

    PubMed  CAS  Google Scholar 

  24. Pihlajamäki KK, Kanto JH, Oksman-Caldentey K-M. Pharmacokinetics and clinical effects of scopolamine in caesarean section patients. Acta Pharm Tox 1986; 59: 259–62

    PubMed  Google Scholar 

  25. Muir C, Metcalfe R. A comparison of plasma levels of hyoscine after oral and transdermal administration. J Pharm Biomed Anal 1983; 1: 363–7

    PubMed  CAS  Google Scholar 

  26. Rowbotham DJ. Current management of postoperative nausea and vomiting. Br J Anaesth 1992; 69 Suppl. 1: 46–59

    Google Scholar 

  27. Reinhart DJ, Klein KW, Schroff E. Transdermal scopolamine for the reduction of postoperative nausea in outpatient ear surgery: a double-blind, randomized study. Anesth Analg. 1994 Sep–Aug; 79(2): 281–4

    PubMed  CAS  Google Scholar 

  28. Sohi HS, Heipel J, Inman KJ, et al. Preoperative transdermal scopolamine does not reduce the level of nausea and frequency of vomiting after laparoscopic cholecystectomy. Can J Surg. 1994 Aug; 37(4): 307–12

    PubMed  CAS  Google Scholar 

  29. Doyle E, Byers G, McNicol LR, et al. Prevention of postoperative nausea and vomiting with transdermal hyoscine in children using patient-controlled analgesia. Br J Anaesth. 1994 Jan; 72(1): 72–6

    PubMed  CAS  Google Scholar 

  30. Bailey PL, Streisand JB, Pace NL, et al. Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy. Anesthesiology. 1990 Jun; 72(6): 977–80

    PubMed  CAS  Google Scholar 

  31. Horimoto Y, Tomie H, Hanzawa K, et al. Scopolamine patch reduces postoperative emesis in paediatric patients following strabismus surgery. Can J Anaesth 1991; 38(4): 441–1

    PubMed  CAS  Google Scholar 

  32. Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In: Gilman AG, Goodman LS, Rall TW, et al., editors. The pharmacological basis of therapeutics. New York: Pergamon Press, 1990; 383–435

    Google Scholar 

  33. Blanc VF, Ruest P, Milot J, et al. Antiemetic prophylaxis with promethazine or droperidol in paediatric outpatient strabismus surgery. Can J Anaesth 1991; 38: 54–60

    PubMed  CAS  Google Scholar 

  34. Wood CD, Graybeil A. The antimotion sickness drugs. Otolaryngol Clin North Am 1973; 6(1): 301–3

    PubMed  CAS  Google Scholar 

  35. Wood CD. Antimotion sickness and antiemetic drugs. Drugs 1979; 17: 471–9

    PubMed  CAS  Google Scholar 

  36. Davis JR, Jennings RT, Beck BG, et al. Treatment efficacy of intramuscular promethazine for space motion sickness. Aviat Space Environ Med. 1993 Mar; 64(3 Pt 1): 230–3

    PubMed  CAS  Google Scholar 

  37. Garrison JC. Histamine bradykinin, 5-hydroxytryptamine, and their antagonist. In: Gilman AG, Rall TW, Nies AS, et al., editors. The pharmacological basis of therapeutics. New York: Pergamon Press; 1990: 575–99

    Google Scholar 

  38. Buzdar Au, Esparza L, Natale R, et al. Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine. A placebo-controlled study. Am J Clin Oncol. 1994 Oct; 17(5): 417–21

    PubMed  CAS  Google Scholar 

  39. Walder AD, Aitkenhead AR. A comparison of droperidol and cyclizine in the prevention of postoperative nausea and vomiting associated with patient-controlled analgesia. Anaesthesia. 1995 Jul; 50(7): 654–6

    PubMed  CAS  Google Scholar 

  40. Synder SH, U’Prichard D, Greenberg DA. Neurotransmitter receptor binding in the brain. In: Lipton MA, DiMascio A, Killam KF, editors. Psychopharmacology: a generation of progress. New York: Raven Press, 1978: 361–70

    Google Scholar 

  41. Hanson CE, Christensen TR, Elley J, et al. Clinical pharmacokinetic studies of perphenazine. Br J Clin Pharmacol 1976; 3: 915–23

    Google Scholar 

  42. Bradley BE, Moore DC. The use of intramuscular perphenazine to control postoperative vomiting. Am J Surg. 1961 Jul; 102: 120–3

    Google Scholar 

  43. Lind B, Breivik H. Metoclopramide and perphenazine in the prevention of postoperative nausea and vomiting; a double blind comparison. Br J Anaesth 1970; 42: 614–7

    PubMed  CAS  Google Scholar 

  44. McGarry JM. A double-blind comparison of the anti-emetic effect during labour of metoclopramide and perphenazine. Br J Anaesth 1971; 43: 613

    PubMed  CAS  Google Scholar 

  45. Robbie DS. Postanaesthetic vomiting and anti-emetic drugs. Anaesthesia 1959; 14: 349–54

    PubMed  CAS  Google Scholar 

  46. Scurr CF, Robbie DS. Trials of perphenazine in the prevention of postoperative vomiting. BMJ 1958; 1: 922–3

    PubMed  CAS  Google Scholar 

  47. Desilva PH, Darvish AH, McDonald SM, et al. The efficacy of prophylactic ondansetron, droperidol, perphenazine, and metoclopramide in the prevention of nausea and vomiting after major gynecologic surgery. Anesth Analg. 1995 Jul; 81(1): 139–43

    PubMed  CAS  Google Scholar 

  48. Cramb R, Fargas-Babjak A, Hirano G. Intraoperative proclorperazine for prevention of postoperative nausea and vomiting. Can J Anaesth. 1989 Sep; 36(5): 565–7

    PubMed  CAS  Google Scholar 

  49. Patterson KW, Armstrong C, Timon D, et al. Buccal prochlorperazine as an antiemetic for day care surgery. Ir Med J. 1993 Nov–Dec; 86(6): 186–8

    PubMed  CAS  Google Scholar 

  50. Loeser EA, Bennett G, Stanley TH, et al. Comparison of droperidol, haloperidol and prochlorperazine as postoperative anti-emetics. Can Anaesth Soc J. 1979 Mar; 26(2): 125–7

    PubMed  CAS  Google Scholar 

  51. Melnick BM. Extrapyramidal reactions to low-dose droperidol. Anesthesiology. 1988 Sep; 69(3): 424–6

    PubMed  CAS  Google Scholar 

  52. Kennedy SK, Longnecker DE. History and principles of anesthesiology. In: Gilman AG, Goodman LS, Rall TW, et al., editors. The pharmacological basis of therapeutics. New York: Pergamon Press, 1990: 269–84

    Google Scholar 

  53. Melnick B, Sawyer R, Karambelkar D, et al. Delayed side effects of droperidol after ambulatory general anesthesia. Anesth Analg 1989; 69: 748–51

    PubMed  CAS  Google Scholar 

  54. Winning TJ, Brock-Utne JG, Downing JW. Nausea and vomiting after anesthesia and minor surgery. Anesth Analg 1977; 56: 674–7

    PubMed  CAS  Google Scholar 

  55. Iwamoto K, Schwartz H. Antiemetic effect of droperidol after ophthalmic surgery. Arch Ophthalmol. 1978 Aug; 96(8): 1378–9

    PubMed  CAS  Google Scholar 

  56. Rita L, Goodarzi M, Seleny F. Effect of low dose droperidol on postoperative vomiting in children. Can Anaesth Soc J. 1981 May; 28(3): 259–62

    PubMed  CAS  Google Scholar 

  57. Eustis S, Lerman J, Smith DR. Effect of droperidol pretreatment on post-anesthetic vomiting in children undergoing strabismus surgery: the minimum effective dose. J Pediatr Ophthalmol Strabismus. 1987 Jul–Aug; 24(4): 165–9

    PubMed  CAS  Google Scholar 

  58. Mortensen PT. Droperidol (Dehydrobenzperidol®): postoperative anti-emetic effect when given intravenously to gynaecological patients. Acta Anaesthesiol Scand 1982; 26: 48–52

    PubMed  CAS  Google Scholar 

  59. Wetchler BV, Collins IS, Jacob L. Antiemetic effects of droperidol on the ambulatory surgery patient. Anesth Rev. 1982 May; 9(5): 23–6

    Google Scholar 

  60. Patton CM, Moon MR, Dannemiller FJ. The prophylactic antiemetic effect of droperidol. Anesth Analg. 1974 May–Jun; 53(3): 361–4

    PubMed  Google Scholar 

  61. McKenzie R, Wadhwa RK, Uy NTL, et al. Antiemetic effectiveness of intramuscular hydroxyzine compared with intramuscular droperidol. Anesth Analg. 1981 Nov; 60(11): 783–8

    PubMed  CAS  Google Scholar 

  62. Gan TJ, Alexander R, Fennelly M, et al. Comparison of different methods of administering droperidol in patient-controlled analgesia in the prevention of postoperative nausea and vomiting. Anesth Analg 1995; 80: 81–5

    PubMed  CAS  Google Scholar 

  63. Pinder RM, Brogden RN, Sawyer PR, et al. Metoclopramide: a review of its pharmacological properties and clinical use. Drugs 1976; 12: 81–131

    PubMed  CAS  Google Scholar 

  64. Harrington RA, Hamilton CW, Brogden RN, et al. Metoclopramide: an updated review of its pharmacological properties and clinical use. Drugs 1983; 25: 451–94

    PubMed  CAS  Google Scholar 

  65. Andrew PL, Rapeport WG, Sanger GJ. Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol Sci. 1988 Sep; 9(9): 334–41

    Google Scholar 

  66. Ross-Lee LM, Hooper WD, Bochner F. Single-dose pharmacokinetics of metoclopramide. Eur J Clin Pharmacol 1981; 20: 465–71

    PubMed  CAS  Google Scholar 

  67. Bateman DN, Kahn C, Davies DS. The pharmacokinetics of metoclopramide in man with observations in the dog. Br J Clin Pharmacol 1980; 9: 371–7

    PubMed  CAS  Google Scholar 

  68. Teng L, Bruce RB, Dunning LK. Metoclopramide metabolism and determination by high-pressure liquid chromatography. J Pharm Sci 1977; 66(11): 1615–8

    PubMed  CAS  Google Scholar 

  69. Graffner C, Lagerström PO, Lundborg P, et al. Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography. Br J Clin Pharmacol 1979; 8(5): 469–74

    PubMed  CAS  Google Scholar 

  70. Bateman DN, Kahn C, Davies DS. Concentration effect studies with oral metoclopramide. Br J Clin Pharmacol. 1979 Aug; 8(2): 179–82

    PubMed  CAS  Google Scholar 

  71. Goslin RH, Garnick MB. Metoclopramide as an antiemetic in patients receiving cisplatin. In: Poster DS, Penta JS, Bruno S, editors. Treatment of cancer chemotherapy-induced nausea and vomiting. New York: Masson Press, 1981: 159–65

    Google Scholar 

  72. Grimes JD, Hassan MN, Preston DN. Adverse neurologic effects of metoclopramide. Can Med Assoc J. 1982 Jan 1; 126(1): 23–5

    PubMed  CAS  Google Scholar 

  73. McCallum RW, Ippoliti AF, Cooner C, et al. A controlled trial of metoclopramide in symptomatic gastroesophageal reflux. N Engl J Med 1977; 296(7): 354–7

    PubMed  CAS  Google Scholar 

  74. Desmond PV, Watson KJR. Metoclopramide — a review. Med J Aust. 1986 Mar 31; 144: 366–9

    PubMed  CAS  Google Scholar 

  75. Schulze-Delrieu K. Metoclopramide. Drug therapy. N Engl J Med. 1981 Jul 2; 305(1): 28–33

    PubMed  CAS  Google Scholar 

  76. Lin DM, Furst SR, Rodarte A. A double-blinded comparison of metoclopramide and droperidol for prevention of emesis following strabismus surgery. Anesthesiology 1992; 76: 357–61

    PubMed  CAS  Google Scholar 

  77. Broadman LM, Ceruzzi W, Patane PS, et al. Metoclopramide reduces the incidence of vomiting following strabismus surgery in children. Anesthesiology 1990; 72: 245–8

    PubMed  CAS  Google Scholar 

  78. Cohen SE, Woods WA, Wyner J. Antiemetic efficacy of droperidol and metoclopramide. Anesthesiology. 1984 Jan; 60(1): 67–9

    PubMed  CAS  Google Scholar 

  79. Madej TH, Simpson KH. Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following gynaecological surgery in day cases. Br J Anaesth 1986; 58: 879–83

    PubMed  CAS  Google Scholar 

  80. Korttila K, Kauste A, Auvinen J. Comparison of domperidone, droperidol, and metoclopramide in the prevention and treatment of nausea and vomiting after balanced general anesthesia. Anesth Analg. 1979 Sep–Oct; 58(5): 396–400

    PubMed  CAS  Google Scholar 

  81. Raphael JH, Norton AC. Antiemetic efficacy of prophylactic ondansetron in laparoscopic surgery: randomized, double-blind comparison with metoclopramide. Br J Anaesth 1993; 71: 845–8

    PubMed  CAS  Google Scholar 

  82. Bunce KT, Tyers MB. The role of 5-HT in postoperative nausea and vomiting. Br J Anaesth 1992; 69 Suppl. 1: 60–2

    Google Scholar 

  83. Markham A, Sorkin EM. Ondansetron: an update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting. Drugs 1993; 45(6): 931–52

    PubMed  CAS  Google Scholar 

  84. Saynor DA, Dixon CM. The metabolism of ondansetron. Eur J Cancer Clin Oncol 1989; 25 Suppl. 1: 75–7

    Google Scholar 

  85. Blackwell CP, Harding SM. The clinical pharmacology of ondansetron. Eur J Cancer Clin Oncol 1989; 25 Suppl. 1: 21–4

    Google Scholar 

  86. Chaffee BJ, Tankanow RM. Ondansetron: the first of a new class of antiemetic agents. Clin Pharm 1991; 10: 430–46

    PubMed  CAS  Google Scholar 

  87. Baber N, Palmer JL, Frazer NM, et al. Clinical pharmacology of ondansetron in postoperative nausea and vomiting. Eur J Anaesth 1992; 9 Suppl. 6: 11–8

    Google Scholar 

  88. Pritchard JF, Bryson JC, Kernodle AE, et al. Age and gender effects on ondansetron pharmacokinetics: evaluation of healthy aged volunteers. Clin Pharmacol Ther 1992; 51: 51–5

    PubMed  CAS  Google Scholar 

  89. Dershwitz M, Di Biase PM, Rosow CE, et al. Ondansetron does not affect alfentanil-induced ventilatory depression or sedation. Anesthesiology. 1992 Sep; 77(3): 447–52

    PubMed  CAS  Google Scholar 

  90. McKenzie R, Kovac A, O’Connor T, et al. Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology 1993; 78: 21–8

    PubMed  CAS  Google Scholar 

  91. Sung Y-F, Wetchler BV, Duncalf D, et al. A double-blind placebo-controlled pilot study examining the effectiveness of intravenous ondansetron in the prevention of postoperative nausea and emesis. J Clin Anesth 1993; 5: 22–9

    PubMed  CAS  Google Scholar 

  92. Khalil SN, Kataria B, Pearson K, et al. Ondansetron prevents postoperative nausea and vomiting in women outpatients. Anesth Analg 1994; 79; 845–51

    PubMed  CAS  Google Scholar 

  93. Bodner M, White PF. Antiemetic efficacy of ondansetron after outpatient laparoscopy. Anesth Analg 1991; 73: 250–4

    PubMed  CAS  Google Scholar 

  94. Scuderi P, Wetchler B, Sung YF, et al. Treatment of postoperative nausea and vomiting after outpatient surgery with the 5-HT3 antagonist ondansetron. Anesthesiology. 1993 Jan; 78(1): 15–20

    PubMed  CAS  Google Scholar 

  95. Rodrigo MRC, Campbell RCH, Chow J, et al. Ondansetron for prevention of postoperative nausea and vomiting following minor oral surgery: a double-blind randomized study. Anaesth Intensive Care 1994; 22: 576–9

    PubMed  CAS  Google Scholar 

  96. Furst SR, Rodart A. Prophylactic antiemetic treatment with ondansetron in children undergoing tonsillectomy. Anesthesiology. 1994 Oct; 81(4): 799–803

    PubMed  CAS  Google Scholar 

  97. Watcha MF, Bras PJ, Cieslak GD, et al. The dose-response relationship of ondansetron in preventing postoperative emesis in pediatric patients undergoing ambulatory surgery. Anesthesiology. 1995 Jan; 82(1): 47–52

    PubMed  CAS  Google Scholar 

  98. Ummenhofer W, Frei FJ, Urwyler A, et al. Effects of ondansetron in the prevention of postoperative nausea and vomiting in children. Anesthesiology. 1994 Oct; 81(4): 804–10

    PubMed  CAS  Google Scholar 

  99. Carroll NV, Miederhoff P, Cox FM, et al. Postoperative nausea and vomiting after discharge from outpatient surgery centers. Anesth Analg 1995; 80: 903–9

    PubMed  CAS  Google Scholar 

  100. Claybon L. Single dose intravenous ondansetron for the 24-hour treatment of postoperative nausea and vomiting. Anaesthesia 1994; 49 Suppl.: 24–9

    PubMed  Google Scholar 

  101. Pearman MH. Single dose intravenous ondansetron in the prevention of postoperative nausea and vomiting. Anaesthesia 1994; 49 Suppl.: 11–5

    PubMed  Google Scholar 

  102. Grond S, Lynch J, Diefenbach C, et al. Comparison of ondansetron and droperidol in the prevention of nausea and vomiting after inpatient minor gynecologic surgery. Anesth Analg. 1995 Sep; 81(3): 603–7

    PubMed  CAS  Google Scholar 

  103. Paxton LD, McKay AC, Mirakhur RK. Prevention of nausea and vomiting after day care gynaecological laparoscopy. A comparison of ondansetron, droperidol, metoclopramide and placebo. Anaesthesia. 1995 May; 50(5): 403–6

    PubMed  CAS  Google Scholar 

  104. Litman RS, Wu CL, Lee A, et al. Prevention of emesis after strabismus repair in children: a prospective, double-blinded, randomized comparison of droperidol versus ondansetron. J Clin Anesth. 1995 Feb; 7(1): 58–62

    PubMed  CAS  Google Scholar 

  105. Gan TJ, Collis R, Hetreed M. Double-blind comparison of ondansetron, droperidol and saline in the prevention of postoperative nausea and vomiting. Br J Anaesth 1994; 72: 544–7

    PubMed  CAS  Google Scholar 

  106. Lewis MA, Fishman DA. Ondansetron for postoperative nausea and vomiting: decisions in the absence of comparative trials. Am J Hosp Pharm. 1994 Feb; 51: 524–5

    PubMed  CAS  Google Scholar 

  107. Mikawa K, Takao Y, Nishina K, et al. The antiemetic efficiacy of prophylactic granisetron in gynecologic surgery. Anesth Analg. 1995 May; 80(5): 970–4

    PubMed  CAS  Google Scholar 

  108. Fujii Y, Tanaka H, Toyooka H. Optimal anti-emetic dose of granisetron for preventing postoperative nausea and vomiting. Can J Anaesth. 1994 Sep; 41(9): 794–7

    PubMed  CAS  Google Scholar 

  109. Zomers PJ, Langenberg CJ, de Bruijn KM. Tropisetron for postoperative nausea and vomiting in patients after gynaecological surgery. Br J Anaesth. 1993 Nov; 71(5): 677–80

    PubMed  CAS  Google Scholar 

  110. Schreiner MS, Nicolson SC, Martin T, et al. Should children drink before discharge from day surgery? Anesthesiology 1992 Apr; 76(4): 528–33

    PubMed  CAS  Google Scholar 

  111. Kamath B, Curran J, Hawkey C, et al. Anaesthesia, movement and emesis. Br J Anesth 1990; 64: 728–30

    CAS  Google Scholar 

  112. Kraynack BJ, Bates MF, Ginautas J. Antiemetic efficacy of ranitidine, metoclopramide and gastric suctioning in outpatient laparoscopy. Anesth Analg 1990; 70 Suppl.: 218

    Google Scholar 

  113. McCarroll SM, Mori S, Bras PJ, et al. The effect of gastric intubation and removal of gastric contents on the incidence of postoperative nausea and vomiting. Anesth Analg 1990; 70 Suppl.: 262

    Google Scholar 

  114. Hovorka J, Korttila K, Erkola O. Gastric aspiration at the end of anaesthesia does not decrease postoperative nausea and vomiting. Anaesth Intensive Care 1990; 18: 58–61

    PubMed  CAS  Google Scholar 

  115. Lonie DS, Harper NJN. Nitrous oxide anaesthesia and vomiting. Anaesthesia 1986; 41: 703–7

    PubMed  CAS  Google Scholar 

  116. Melnick BM, Johnson LS. Effects of eliminating nitrous oxide in outpatient anesthesia. Anesthesiology. 1987 Dec; 67(6): 982–4

    PubMed  CAS  Google Scholar 

  117. Felts JA, Poler SM, Spitznagel EL. Nitrous oxide, nausea, and vomiting after outpatient gynecologic surgery. J Clin Anesth. 1990 May–Jun; 2: 168–71

    PubMed  CAS  Google Scholar 

  118. Muir JJ, Warner MA, Offord KP, et al. Role of nitrous oxide and other factors in postoperative nausea and vomiting: a randomized and blinded prospective study. Anesthesiology. 1987 Apr; 66(4): 513–8

    PubMed  CAS  Google Scholar 

  119. Korttila K, Hovorka J, Erkola O. Nitrous oxide does not increase the incidence of nausea and vomiting after isoflurane anesthesia. Anesth Analg 1987; 66: 761–5

    PubMed  CAS  Google Scholar 

  120. Sengupta P, Plantevin OM. Nitrous oxide and day-case laparoscopy: effects on nausea, vomiting and return to normal activity. Br J Anaesth 1988; 60: 570–3

    PubMed  CAS  Google Scholar 

  121. Hovorka J, Korttila K. Nitrous oxide does not increase nausea and vomiting following gynaecological laparoscopy. Can J Anaesth 1989; 36(2): 145–8

    PubMed  CAS  Google Scholar 

  122. Borgeat A. Effects of diprivan on nausea and vomiting [in French]. Ann Fr Anesth Reanim 1994; 13(4): 576–8

    PubMed  CAS  Google Scholar 

  123. Ostman PL, Faure E, Glosten B, et al. Is the antiemetic effect of the emulsion formulation of propofol due to the lipid emulsion? Anesth Analg 1990 Nov: 71(5): 536–40

    PubMed  CAS  Google Scholar 

  124. Wagner BK, Berman SL, Devitt PA, et al. Retrospective analysis of postoperative nausea and vomiting to determine antiemetic activity of droperidol added to propofol: a possible drug interaction. Pharmacotherapy. 1994 Sep–Oct; 14(5): 586–91

    PubMed  CAS  Google Scholar 

  125. Kohl RL, Calkins DS, Mandell AJ. Arousal and stability: the effects of five new sympathomimetic drugs suggest a new principle for the prevention of space motion sickness. Aviat Space Environ Med. 1986 Feb; 57(2): 137–43

    PubMed  CAS  Google Scholar 

  126. Rothenberg DM, Parnass SM, Litwack K, et al. Efficacy of ephedrine in the prevention of postoperative nausea and vomiting. Anesth Analg 1991; 72: 58–61

    PubMed  CAS  Google Scholar 

  127. Liu Y-C, Kang H-M, Liou C-M, et al. Comparison of antiemetic effect among ephedrine, droperidol and metoclopramide in pediatric inguinal hernioplasty. Acta Anaesthesiol Sin 1992; 30(1): 37–42

    CAS  Google Scholar 

  128. Dundee JW, Chestnutt WN, Ghaly RB, et al. Traditional Chinese acupuncture: a potentially useful antiemetic? BMJ 1986 Sept 6; 293: 583–4

    Google Scholar 

  129. Ho RT, Jawan B, Fung ST, et al. Electro-acupuncture and postoperative emesis. Anesthesia 1989; 45: 327–9

    Google Scholar 

  130. Yentis SM, Bissonnette B. P6 acupuncture and postoperative vomiting after tonsillectomy in children. Br J Anaesth 1991; 67: 779–80

    PubMed  CAS  Google Scholar 

  131. Lewis IH, Pryn SJ, Reynolds PI, et al. Effect of P6 acupressure on postoperative vomiting in children undergoing outpatient strabismus correction. Br J Anaesth 1991; 67: 73–8

    PubMed  CAS  Google Scholar 

  132. Mowrey DB, Clayson DE. Motion sickness, ginger, and psychophysics. Lancet. 1982 Mar; 20: 655–6

    Google Scholar 

  133. Grontved A, Brask T, Kambskard J, et al. Ginger root against seasickness. A controlled trial on the open sea. Acta Otolaryngol. 1988 Jan–Feb; 105(1–2): 45–9

    PubMed  CAS  Google Scholar 

  134. Stewart JJ, Wood MJ, Wood CD, et al. Effects of ginger on motion sickness susceptibility and gastric function. Pharmacology 1991; 42(2): 111–20

    PubMed  CAS  Google Scholar 

  135. Phillips S, Ruggier R, Hutchinson SE. Zingiber officinale (ginger) — an antiemetic for day case surgery. Anaesthesia. 1993 Aug; 48(8): 715–7

    PubMed  CAS  Google Scholar 

  136. Michaloudis D, O’Keeffe N, O’sullivan K, et al. Postoperative nausea and vomiting: a comparison of anti-emetic drugs used alone or in combination. J R Soc Med. 1993 Mar; 86: 137–8

    PubMed  CAS  Google Scholar 

  137. McKenzie R, Tantisira B, Karambelkar DJ, et al. Comparison of ondansetron with ondansetron plus dexamethasone in the prevention of postoperative nausea and vomiting. Anesth Analg 1994; 79: 961–4

    PubMed  CAS  Google Scholar 

  138. Doze VA, Shafer A, White PF. Nausea and vomiting after outpatient anesthesia: effectiveness of droperidol alone and in combination with metoclopramide. Anesth Analg 1987; 66 Suppl.: S41

    Google Scholar 

  139. Pandit SK, Kothary SP, Pandit UA, et al. Dose-response study of droperidol and metoclopramide as antiemetics for outpatient anesthesia. Anesth Analg 1989; 68: 798–802

    PubMed  CAS  Google Scholar 

  140. Kris MG, Gralla RJ, Clark RA, et al. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. Cancer. 1987 Dec; 60(11): 2816–22

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anaesthesiology, Ambulatory Surgery Center, The Emory Clinic and Emory University School of Medicine, 1365-B Clifton Road, NE Atlanta, Georgia, 30322, USA

    Yung-Fong Sung

Authors
  1. Yung-Fong Sung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yung-Fong Sung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sung, YF. Risks and Benefits of Drugs Used in the Management of Postoperative Nausea and Vomiting. Drug-Safety 14, 181–197 (1996). https://doi.org/10.2165/00002018-199614030-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199614030-00005

Keywords

Search

Navigation